loadpatents
name:-0.37057399749756
name:-0.41562008857727
name:-0.0046558380126953
Kaufman; Michael D. Patent Filings

Kaufman; Michael D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kaufman; Michael D..The latest application filed is for "amorphous kinase inhibitor formulations and methods of use thereof".

Company Profile
3.31.52
  • Kaufman; Michael D. - Waltham MA
  • Kaufman; Michael D. - Lawrence KS
  • Kaufman; Michael D - Lawrence KS
  • Kaufman, Michael D. - Ypsilanti MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof
App 20220265622 - Kaufman; Michael D. ;   et al.
2022-08-25
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof
App 20220265623 - Kaufman; Michael D. ;   et al.
2022-08-25
Compositions Of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-- 3-yl)-2-fluorophenyl)-3-phenylurea
App 20220257574 - Kaufman; Michael D. ;   et al.
2022-08-18
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-- 3-yl)-2-fluorophenyl)-3-phenylurea
Grant 11,395,818 - Kaufman , et al. July 26, 2
2022-07-26
Use Of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthy- Ridin-3-yl]-2-fluorophenyl]-3-phenylurea And Analogs For The Treatment Of Cancers Associated With Genetic Abnormalities In Platelet Derived Growth Factor Receptor Alpha
App 20220031678 - Flynn; Daniel L. ;   et al.
2022-02-03
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof
App 20220031677 - Kaufman; Michael D. ;   et al.
2022-02-03
Amorphous kinase inhibitor formulations and methods of use thereof
Grant 11,185,535 - Kaufman , et al. November 30, 2
2021-11-30
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant RE48,731 - Flynn , et al. September 14, 2
2021-09-14
Compositions Of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-- 3-yl)-2-fluorophenyl)-3-phenylurea
App 20210196693 - Kaufman; Michael D. ;   et al.
2021-07-01
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof
App 20210196692 - Kaufman; Michael D. ;   et al.
2021-07-01
Use Of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthy- Ridin-3-yl]-2-fluorophenyl]-3-phenylurea And Analogs For The Treatment Of Cancers Associated With Genetic Abnormalities In Platelet Derived Growth Factor Receptor Alpha
App 20210015801 - Flynn; Daniel L. ;   et al.
2021-01-21
Use Of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthy- Ridin-3-yl]-2-fluorophenyl]-3-phenylurea And Analogs
App 20200129489 - Flynn; Daniel L. ;   et al.
2020-04-30
Methods For Inhibiting Tie-2 Kinase Useful In The Treatment Of Cancer
App 20190091217 - FLYNN; Daniel L. ;   et al.
2019-03-28
Methods For Inhibiting Tie-2 Kinase Useful In The Treatment Of Cancer
App 20170209428 - Flynn; Daniel L. ;   et al.
2017-07-27
Inhibition Of Tumor Cell Interactions With The Microenvironment Resulting In A Reduction In Tumor Growth And Disease Progression
App 20170079966 - FLYNN; Daniel L. ;   et al.
2017-03-23
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
Grant 9,457,019 - Flynn , et al. October 4, 2
2016-10-04
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,387,202 - Flynn , et al. July 12, 2
2016-07-12
N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,382,228 - Flynn , et al. July 5, 2
2016-07-05
RAF inhibitor compounds
Grant 9,334,267 - Flynn , et al. May 10, 2
2016-05-10
Inhibition Of Trk Kinase Mediated Tumor Growth And Disease Progression
App 20160101090 - FLYNN; Daniel L. ;   et al.
2016-04-14
N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,309,224 - Flynn , et al. April 12, 2
2016-04-12
Imidazolidinones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20160046619 - Flynn; Daniel L. ;   et al.
2016-02-18
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,193,719 - Flynn , et al. November 24, 2
2015-11-24
Raf inhibitor compounds
Grant 9,187,474 - Flynn , et al. November 17, 2
2015-11-17
Dihydronaphthyridines And Related Compounds Useful As Kinase Inhibitors For The Treatment Of Proliferative Diseases
App 20150320759 - Flynn; Daniel L. ;   et al.
2015-11-12
2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,181,223 - Kaufman , et al. November 10, 2
2015-11-10
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,133,183 - Flynn , et al. September 15, 2
2015-09-15
Methods For Inhibiting Tie-2 Kinase Useful In The Treatment Of Cancer
App 20150246033 - Flynn; Daniel L. ;   et al.
2015-09-03
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20150218130 - Flynn; Daniel L. ;   et al.
2015-08-06
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20150148380 - FLYNN; Daniel L. ;   et al.
2015-05-28
Raf Inhibitor Compounds
App 20150119392 - Flynn; Daniel L. ;   et al.
2015-04-30
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 9,012,635 - Flynn , et al. April 21, 2
2015-04-21
Raf Inhibitor Compounds
App 20150105367 - Flynn; Daniel L. ;   et al.
2015-04-16
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant 8,940,756 - Flynn , et al. January 27, 2
2015-01-27
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,921,565 - Flynn , et al. December 30, 2
2014-12-30
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140343103 - Flynn; Daniel L. ;   et al.
2014-11-20
Imidazolidinones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140315917 - Flynn; Daniel L. ;   et al.
2014-10-23
1,2,4-triazol-5-ones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140296252 - Flynn; Daniel L. ;   et al.
2014-10-02
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
App 20140275016 - Flynn; Daniel L. ;   et al.
2014-09-18
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
App 20140275080 - Flynn; Daniel L. ;   et al.
2014-09-18
2-aminopyrimidin-6-ones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140275085 - Kaufman; Michael D. ;   et al.
2014-09-18
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20140194405 - Flynn; Daniel L. ;   et al.
2014-07-10
Raf inhibitor compounds
Grant 8,741,911 - Allgeier , et al. June 3, 2
2014-06-03
Dihydronaphthyridines And Related Compounds Useful As Kinase Inhibitors For The Treatment Of Proliferative Diseases
App 20140088075 - Flynn; Daniel L. ;   et al.
2014-03-27
Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,637,672 - Flynn , et al. January 28, 2
2014-01-28
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20130317066 - Flynn; Daniel L. ;   et al.
2013-11-28
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,569,319 - Flynn , et al. October 29, 2
2013-10-29
Raf Inhibitor Compounds
App 20130252977 - Allgeier; Matthew Carl ;   et al.
2013-09-26
Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
Grant 8,486,951 - Flynn , et al. July 16, 2
2013-07-16
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant 8,461,179 - Flynn , et al. June 11, 2
2013-06-11
Cyclopropane Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20130079362 - Flynn; Daniel L. ;   et al.
2013-03-28
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120322834 - Flynn; Daniel L. ;   et al.
2012-12-20
Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
App 20120289540 - Flynn; Daniel L. ;   et al.
2012-11-15
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120252849 - Flynn; Daniel L. ;   et al.
2012-10-04
N-acyl ureas exhibiting anti-cancer and anti-proliferative activities
Grant 8,278,331 - Flynn , et al. October 2, 2
2012-10-02
Methods And Compositions For The Treatment Of Myeloproliferative Diseases And Other Proliferative Diseases
App 20120225057 - Flynn; Daniel L. ;   et al.
2012-09-06
Pyridone Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120172382 - Flynn; Daniel L. ;   et al.
2012-07-05
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Grant 8,188,113 - Flynn , et al. May 29, 2
2012-05-29
Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
Grant 8,143,293 - Flynn , et al. March 27, 2
2012-03-27
Cyclopropyl Dicarboxamides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20120058985 - FLYNN; DANIEL L. ;   et al.
2012-03-08
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
App 20110189167 - FLYNN; Daniel L. ;   et al.
2011-08-04
Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases
App 20110136760 - Flynn; Daniel L. ;   et al.
2011-06-09
Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
App 20110118271 - FLYNN; Daniel L. ;   et al.
2011-05-19
Kinase inhibitors useful for the treatment of proliferative diseases
Grant 7,897,762 - Flynn , et al. March 1, 2
2011-03-01
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
Grant 7,790,756 - Flynn , et al. September 7, 2
2010-09-07
Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
Grant 7,723,536 - Smith, III , et al. May 25, 2
2010-05-25
Cyclopropane Amides And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities
App 20100120806 - Flynn; Daniel L. ;   et al.
2010-05-13
Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
App 20090187031 - Smith, III; Amos B. ;   et al.
2009-07-23
Kinase inhibitors useful for the treatment of proliferative diseases
App 20090099190 - Flynn; Daniel L. ;   et al.
2009-04-16
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080269254 - Flynn; Daniel L. ;   et al.
2008-10-30
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080269267 - Flynn; Daniel L. ;   et al.
2008-10-30
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080261961 - Flynn; Daniel L. ;   et al.
2008-10-23
Kinase Inhibitors Useful For The Treatment Of Myleoprolific Diseases And Other Proliferative Diseases
App 20080261965 - Flynn; Daniel L. ;   et al.
2008-10-23
Kinase inhibitors useful for the treatment of proliferative diseases
App 20080114006 - Flynn; Daniel L. ;   et al.
2008-05-15
Kinase Inhibitors Useful For The Treatment Of Myleoproliferative Diseases And Other Proliferative Diseases
App 20080090856 - Flynn; Daniel L. ;   et al.
2008-04-17
MEK inhibiting compounds
App 20050004186 - Barrett, Stephen D. ;   et al.
2005-01-06
Company Registrations
SEC0000897931KAUFMAN MICHAEL D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed